[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Viridian Therapeutics Inc 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 USA

www.viridiantherapeutics.com Employees: 252 P: 617-272-4600 F: 720-293-1930

Sector:

Medical

Description:

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

Key Statistics

Overview:

Market Capitalization, $K 1,845,042
Enterprise Value, $K 1,814,662
Shares Outstanding, K 103,075
Float, K 100,601
% Float 97.60%
Short Interest, K 14,597
Short Float 14.16%
Days to Cover 7.89
Short Volume Ratio 0.62
% of Insider Shareholders 2.40%

Financials:

Annual Sales, $ 70,850 K
Annual Net Income, $ -342,600 K
Last Quarter Sales, $ 140 K
Last Quarter Net Income, $ -104,900 K
EBIT, $ -385,700 K
EBITDA, $ -392,000 K

Growth:

1-Year Return 23.02%
3-Year Return -24.76%
5-Year Return 1.24%
5-Year Revenue Growth 6,647.62%
5-Year Earnings Growth 71.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.90 on 05/05/26
Next Earnings Date 08/05/26
Earnings Per Share ttm -3.32
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year -3.45%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/13/20

VRDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -80.19%
Return-on-Assets % -48.84%
Profit Margin % -483.56%
Debt/Equity 0.08
Price/Sales 26.04
Price/Cash Flow N/A
Price/Book 3.56
Book Value/Share 6.17
Interest Coverage -68.21
60-Month Beta 0.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.